These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


327 related items for PubMed ID: 15745043

  • 1. Past and present vaccine development strategies for the control of foot-and-mouth disease.
    Balamurugan V, Kumar RM, Suryanarayana VV.
    Acta Virol; 2004; 48(4):201-14. PubMed ID: 15745043
    [Abstract] [Full Text] [Related]

  • 2. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ.
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [Abstract] [Full Text] [Related]

  • 3. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P, Li XM, Jin ML, Peng GQ, Chen HC.
    Vaccine; 2004 Jun 02; 22(17-18):2129-36. PubMed ID: 15149769
    [Abstract] [Full Text] [Related]

  • 4. [Expression of foot and mouth disease virus antigens in transgenic plants].
    Dus Santos MJ, Wigdorovitz A.
    Rev Sci Tech; 2005 Apr 02; 24(1):175-87. PubMed ID: 16110887
    [Abstract] [Full Text] [Related]

  • 5. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
    Ren ZJ, Tian CJ, Zhu QS, Zhao MY, Xin AG, Nie WX, Ling SR, Zhu MW, Wu JY, Lan HY, Cao YC, Bi YZ.
    Vaccine; 2008 Mar 10; 26(11):1471-81. PubMed ID: 18289743
    [Abstract] [Full Text] [Related]

  • 6. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X, Liu R, Tang H, Jin M, Chen H, Qian P.
    Vaccine; 2008 May 23; 26(22):2714-22. PubMed ID: 18436351
    [Abstract] [Full Text] [Related]

  • 7. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
    Blignaut B, Visser N, Theron J, Rieder E, Maree FF.
    J Gen Virol; 2011 Apr 23; 92(Pt 4):849-59. PubMed ID: 21177923
    [Abstract] [Full Text] [Related]

  • 8. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV, Wilda M, Bucafusco D, de los Ángeles Lavoria M, Franco-Mahecha OL, Mansilla FC, Pérez-Filgueira DM, Grigera PR.
    Antiviral Res; 2011 Nov 23; 92(2):219-27. PubMed ID: 21889542
    [Abstract] [Full Text] [Related]

  • 9. Development of vaccines toward the global control and eradication of foot-and-mouth disease.
    Rodriguez LL, Gay CG.
    Expert Rev Vaccines; 2011 Mar 23; 10(3):377-87. PubMed ID: 21434805
    [Abstract] [Full Text] [Related]

  • 10. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
    Zheng M, Jin N, Zhang H, Jin M, Lu H, Ma M, Li C, Yin G, Wang R, Liu Q.
    J Virol Methods; 2006 Sep 23; 136(1-2):230-7. PubMed ID: 16780963
    [Abstract] [Full Text] [Related]

  • 11. Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs.
    Yao Q, Qian P, Huang Q, Cao Y, Chen H.
    J Virol Methods; 2008 Jan 23; 147(1):143-50. PubMed ID: 17963851
    [Abstract] [Full Text] [Related]

  • 12. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ, Muller JD, Yu M, Wang LF, Heine HG.
    J Immunol Methods; 2007 Apr 10; 321(1-2):142-51. PubMed ID: 17328909
    [Abstract] [Full Text] [Related]

  • 13. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.
    Balamurugan V, Renji R, Venkatesh G, Reddy GR, Nair SP, Ganesh K, Suryanarayana VV.
    Arch Virol; 2005 May 10; 150(5):967-79. PubMed ID: 15662485
    [Abstract] [Full Text] [Related]

  • 14. Engineering better vaccines for foot-and-mouth disease.
    Mason PW, Chinsangaram J, Moraes MP, Mayr GA, Grubman MJ.
    Dev Biol (Basel); 2003 May 10; 114():79-88. PubMed ID: 14677679
    [Abstract] [Full Text] [Related]

  • 15. Foot and mouth disease virus vaccines.
    Rodriguez LL, Grubman MJ.
    Vaccine; 2009 Nov 05; 27 Suppl 4():D90-4. PubMed ID: 19837296
    [Abstract] [Full Text] [Related]

  • 16. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
    Borrego B, Fernandez-Pacheco P, Ganges L, Domenech N, Fernandez-Borges N, Sobrino F, Rodríguez F.
    Vaccine; 2006 May 01; 24(18):3889-99. PubMed ID: 16563575
    [Abstract] [Full Text] [Related]

  • 17. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
    Fowler VL, Paton DJ, Rieder E, Barnett PV.
    Vaccine; 2008 Apr 07; 26(16):1982-9. PubMed ID: 18342409
    [Abstract] [Full Text] [Related]

  • 18. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
    Cox SJ, Voyce C, Parida S, Reid SM, Hamblin PA, Hutchings G, Paton DJ, Barnett PV.
    Vaccine; 2006 Apr 12; 24(16):3184-90. PubMed ID: 16488060
    [Abstract] [Full Text] [Related]

  • 19. Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost.
    Li Y, Stirling CM, Denyer MS, Hamblin P, Hutchings G, Takamatsu HH, Barnett PV.
    Vaccine; 2008 May 19; 26(21):2647-56. PubMed ID: 18321615
    [Abstract] [Full Text] [Related]

  • 20. Immune enhancing effects of recombinant bovine IL-18 on foot-and-mouth disease vaccination in mice model.
    Shi XJ, Wang B, Wang M.
    Vaccine; 2007 Jan 26; 25(7):1257-64. PubMed ID: 17084491
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.